CoChat

Functional interplay between the DNA-damage-response kinase ATM and ARF tumour suppressor protein in human cancer

Open access

The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.

Abstract

The DNA damage response (DDR) pathway and ARF function as barriers to cancer development. Although commonly regarded as operating independently of each other, some studies proposed that ARF is positively regulated by the DDR. Contrary to either scenario, we found that in human oncogene-transformed and cancer cells, ATM suppressed ARF protein levels and activity in a transcription-independent manner. Mechanistically, ATM activated protein phosphatase 1, which antagonized Nek2-dependent phosphorylation of nucleophosmin (NPM), thereby liberating ARF from NPM and rendering it susceptible to degradation by the ULF E3-ubiquitin ligase. In human clinical samples, loss of ATM expression correlated with increased ARF levels and in xenograft and tissue culture models, inhibition of ATM stimulated the tumour-suppressive effects of ARF. These results provide insights into the functional interplay between the DDR and ARF anti-cancer barriers, with implications for tumorigenesis and treatment of advanced tumours.

Overview

Integrity signals

Registry

Crossref · 10.1038/ncb2795

Cites

75 of 75 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 75 references

Cited by

Metadata

Authors
Velimezi, G., Liontos, M., Vougas, K., Roumeliotis, T., Bartkova, J., Sideridou, M., Dereli-Oz, A., Kocylowski, M., Pateras, I. S., Evangelou, K., Kotsinas, A., Orsolic, I., Bursac, S., Cokaric-Brdovcak, M., Zoumpourlis, V., Kletsas, D., Papafotiou, G., Klinakis, A., Volarevic, S., Gu, W., Bartek, J., Halazonetis, T. D., & Gorgoulis, V. G.
Affiliations
  • National and Kapodistrian University of Athens (GR)
  • Biomedical Research Foundation of the Academy of Athens (GR)
  • University of Geneva (CH)
  • Danish Cancer Society (DK)
  • National Hellenic Research Foundation (GR)
  • National Centre of Scientific Research "Demokritos" (GR)
  • Columbia University (US)
Corresponding author
Gorgoulis, Vassilis G.
Venue
Nature Cell Biology
Published
2013-07-14
Volume
15
Issue
8
Pages
967-977
ISSN
  • 1465-7392 (ISSN-L)
  • 1476-4679
OpenAlex
W2039467788
Cited by
131
References
75
Citations by year
2026: 2 · 2025: 6 · 2024: 4 · 2023: 2 · 2022: 3 · 2021: 7 · 2020: 9 · 2019: 6 · 2018: 14 · 2017: 11 · 2016: 28 · 2015: 14 · 2014: 20 · 2013: 5
FWCI
11.95
Type
journal article
Language
en
Update notices
erratum (2013-10-01)
Open access
Licence
Locations
  • Nature Cell Biology (publishedVersion)
  • PubMed (publishedVersion)
  • Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
Topics
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
Keywords
ATM kinase, DNA damage response, tumor suppression, protein phosphatase 1, NEK2, protein degradation, oncogene-transformed cells, carcinogenesis, ATM inhibition
MeSH terms
NIMA-Related Kinases, Animals, Carrier Proteins, Cell Cycle, Cell Line, DNA-Binding Proteins, HeLa Cells, Humans, Male, Neoplasms, Phosphorylation, Ribosomes, Transplantation, Heterologous, Signal Transduction, Gene Expression Regulation, Neoplastic, Protein Serine-Threonine Kinases, Cell Cycle Proteins, ADP-Ribosylation Factor 1, Tumor Suppressor Protein p14ARF, Ubiquitin-Protein Ligases, Cell Line, Tumor, Mice, Protein Stability, Ataxia Telangiectasia Mutated Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.